Results 181 to 190 of about 7,748 (215)
Some of the next articles are maybe not open access.

Genetic engineering of immunotoxins

1988
Genetic engineering offers many advantages for the 1) production of immunotoxins (ITs) and 2) design of more effective reagents. In Chapter 9, J.R. Murphy discusses the use of genetic engineering to link genes together resulting in chimeric proteins. This review covers the first applications of genetic engineering technology to improve ITs by studying ...
R J, Youle, L, Greenfield, V G, Johnson
openaire   +2 more sources

Immunotoxins

Scientific American, 1984
R J, Collier, D A, Kaplan
openaire   +2 more sources

Immunotoxins in cancer therapy

Current Opinion in Immunology, 1999
Immunotoxins are composed of a protein toxin connected to a binding ligand such as an antibody or growth factor. These molecules bind to surface antigens (which internalize) and kill cells by catalytic inhibition of protein synthesis within the cell cytosol.
openaire   +2 more sources

Anti-cancer Immunotoxins, Challenges, and Approaches

Current Pharmaceutical Design, 2021
Leila Rahbarnia   +2 more
exaly  

Immunotoxins

2009
Arthur E. Frankel   +2 more
openaire   +2 more sources

Immunotoxins

Clinical Immunotherapeutics, 1994
openaire   +2 more sources

Immunotoxins for Treatment of Leukemia and Lymphoma

Leukemia and Lymphoma, 1995
Fatih M Uçkun
exaly  

Home - About - Disclaimer - Privacy